Insider · CIK 0001206199

WELCH DANIEL G

Reports to the SEC for 10 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001206199

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	GPCRStructure Therapeutics Inc. · Share Option (right to buy)A Award	Director	AAward	+39.5K sh	—	—	39,453
2026-05-15	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Director	AAward	+27K sh	—	—	27,000
2026-05-14	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+7,751 sh	—	—	40,441
2026-05-14	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.1K sh	—	—	14,058
2025-06-23	GPCRStructure Therapeutics Inc. · Share Option (right to buy)A Award	Director	AAward	+51.8K sh	—	—	51,804
2025-05-15	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+5,740 sh	—	—	32,690
2025-05-15	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.8K sh	—	—	10,787
2025-05-14	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Director	AAward	+20.2K sh	—	—	20,183
2024-06-25	GPCRStructure Therapeutics Inc. · Share Option (right to buy)A Award	Director	AAward	+37.5K sh	—	—	37,500
2024-06-18	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+5,345 sh	—	—	26,950
2024-06-18	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,900 sh	—	—	9,900
2024-05-24	NUVBNuvation Bio Inc.M Exercise/Conversion	Director	MExercise/Conversion	+293K sh	$1.74	+$510K	293,203
2024-05-24	NUVBNuvation Bio Inc.M Exercise/Conversion	Director	MExercise/Conversion	+367K sh	$1.64	+$601K	659,947
2024-05-24	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−293K sh	—	—	19,547
2024-05-24	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−367K sh	—	—	0
2024-05-15	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2024-02-21	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Director	AAward	+132K sh	—	—	132,000
2023-12-14	Seagen Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−4,750 sh	$229.00	−$1.09M	0
2023-12-14	Seagen Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−10.7K sh	$229.00	−$2.46M	0
2023-12-14	Seagen Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−2,044 sh	—	—	0
2023-08-28	Seagen Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,812 sh	$135.63	+$246K	10,109
2023-08-28	Seagen Inc.S Sale	Director	SSale	−1,503 sh	$209.16	−$314K	8,606
2023-08-28	Seagen Inc.S Sale	Director	SSale	−1,812 sh	$209.01	−$379K	6,794
2023-08-28	Seagen Inc.S Sale	Director	SSale	−1,610 sh	$209.08	−$337K	10,725
2023-08-28	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,812 sh	—	—	0
2023-08-03	GPCRStructure Therapeutics Inc. · Stock option (right to buy)J Other	Director	JOther	−411K sh	$7.97	−$3.28M	768,122
2023-08-03	GPCRStructure Therapeutics Inc. · Stock option (right to buy)J Other	Director	JOther	+206K sh	$7.97	+$1.64M	205,500
2023-08-03	GPCRStructure Therapeutics Inc. · Stock option (right to buy)J Other	Director	JOther	+206K sh	$7.97	+$1.64M	205,500
2023-06-07	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+3,860 sh	—	—	21,605
2023-06-07	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,110 sh	—	—	7,110
2023-05-31	Seagen Inc.A Award	Director	AAward	+2,044 sh	—	—	8,297
2023-05-15	Seagen Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,864 sh	$135.63	+$253K	8,117
2023-05-15	Seagen Inc.S Sale	Director	SSale	−1,864 sh	$200.02	−$373K	6,253
2023-05-15	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,864 sh	—	—	1,812
2023-05-15	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+367K sh	—	—	366,744
2023-05-02	Seagen Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,888 sh	$64.38	+$122K	8,492
2023-05-02	Seagen Inc.S Sale	Director	SSale	−1,888 sh	$200.05	−$378K	6,604
2023-05-02	Seagen Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,171 sh	$160.33	+$508K	9,775
2023-05-02	Seagen Inc.S Sale	Director	SSale	−3,171 sh	$200.05	−$634K	6,604
2023-05-02	Seagen Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,462 sh	$147.50	+$511K	10,066
2023-05-02	Seagen Inc.S Sale	Director	SSale	−3,462 sh	$200.10	−$693K	6,604
2023-05-02	Seagen Inc.S Sale	Director	SSale	−351 sh	$200.07	−$70.2K	6,253
2023-05-02	Seagen Inc.S Sale	Director	SSale	−5,835 sh	$200.07	−$1.17M	12,335
2023-05-02	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,888 sh	—	—	0
2023-05-02	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,171 sh	—	—	0
2023-05-02	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,462 sh	—	—	0
2023-05-01	Seagen Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,150 sh	$64.38	+$332K	12,049
2023-05-01	Seagen Inc.S Sale	Director	SSale	−5,150 sh	$200.04	−$1.03M	6,899
2023-05-01	Seagen Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,990 sh	$56.77	+$113K	8,889
2023-05-01	Seagen Inc.S Sale	Director	SSale	−1,990 sh	$200.12	−$398K	6,899

Recent filings

Accepted (ET)
Jun 184
WELCH DANIEL G0001206199-26-000002
SEC(opens sec.gov)
May 184
WELCH DANIEL G0001193125-26-229224
SEC(opens sec.gov)
May 154
WELCH DANIEL G0000905148-26-002471
SEC(opens sec.gov)
Jun 254
WELCH DANIEL G0001415889-25-018213
SEC(opens sec.gov)
May 194
WELCH DANIEL G0000950170-25-074667
SEC(opens sec.gov)
May 164
WELCH DANIEL G0000905148-25-001836
SEC(opens sec.gov)
Jun 274
WELCH DANIEL G0001415889-24-018324
SEC(opens sec.gov)
Jun 204
WELCH DANIEL G0000950170-24-075488
SEC(opens sec.gov)
May 294
WELCH DANIEL G0001415889-24-014769
SEC(opens sec.gov)
May 174
WELCH DANIEL G0000905148-24-001542
SEC(opens sec.gov)
Feb 234
WELCH DANIEL G0000905148-24-000791
SEC(opens sec.gov)
Dec 154
WELCH DANIEL G0000950170-23-070874
SEC(opens sec.gov)

Companies

Address

C/O STRUCTURE THERAPEUTICS INC. 601 GATEWAY BLVD., SUITE 900

SOUTH SAN FRANCISCO, CA, 94080